发明名称 |
CHIMERIC MOLECULES AND METHODS OF USE |
摘要 |
Chimeric molecules comprising endostatin and all or a portion of an Ig (Ig) molecule are used to treat tumors. A chimeric molecule, including endostatin fused to an Ig domain of an anti-HER2/neu antibody exhibited longer serum half-life and stability than native endostatin. <SUP>125</SUP>I-labeled anti HER2/neu IgG3-endostatin chimeric molecule and anti-HER2/neu IgG3-endostatin was 6 fold faster than that of anti-HER2/neu IgG3 (CLss=0.374 and 0.062ml/min/kg, respectively), however, the specific tumor radiolocalization indices of anti-HER2/neu IgG3-endostatin were greater than those of anti-HER2/neu IgG3. Anti-HER2/neu IgG3-endostatin inhibited tumor growth more effectively than endostatin alone, anti-HER2/neu IgG3 antibody, or the combination of antibody and endostatin. |
申请公布号 |
WO2005021710(A3) |
申请公布日期 |
2008.01.17 |
申请号 |
WO2004US17119 |
申请日期 |
2004.06.02 |
申请人 |
UNIVERSITY OF MIAMI |
发明人 |
SHIN, SEUNG-UON;MORRISON, SHERIE, L.;ROSENBLATT, JOSEPH, D. |
分类号 |
C12P21/08;A61K39/00;C07H21/04;C07K14/78;C07K16/28;C07K16/32;C07K16/46 |
主分类号 |
C12P21/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|